Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Eiichi TanakaYutaka KawahitoMasataka KohnoShintaro HirataKishimoto MitsumasaYuko KanekoHiroya TamaiYohei SetoAkio MorinobuTakahiko SugiharaAtsuko MurashimaMasayo KojimaMasaaki MoriHiromu ItoToshihisa KojimaYasumori SobueKeiichiro NishidaIsao MatsushitaTakeo NakayamaHisashi YamanakaMasayoshi HarigaiPublished in: Modern rheumatology (2021)
Biosimilars and reference bDMARDs were equally useful for the management of RA.